NZ706735A - Humanized anti-cxcr5 antibodies, derivatives thereof and their uses - Google Patents

Humanized anti-cxcr5 antibodies, derivatives thereof and their uses

Info

Publication number
NZ706735A
NZ706735A NZ706735A NZ70673508A NZ706735A NZ 706735 A NZ706735 A NZ 706735A NZ 706735 A NZ706735 A NZ 706735A NZ 70673508 A NZ70673508 A NZ 70673508A NZ 706735 A NZ706735 A NZ 706735A
Authority
NZ
New Zealand
Prior art keywords
derivatives
humanized anti
cxcr5 antibodies
cxcr5
antibodies
Prior art date
Application number
NZ706735A
Inventor
Beatrice Cameron
Vincent Mikol
Renata Lee
Nicolas Baurin
Norman Ruetsch
Thomas Oligino
Elizabeth Allen
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NZ706735A publication Critical patent/NZ706735A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Disclosed is an isolated human or a humanized polypeptide that specifically binds to the extracellular domain of human CXCR5.
NZ706735A 2007-08-29 2008-08-27 Humanized anti-cxcr5 antibodies, derivatives thereof and their uses NZ706735A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96879207P 2007-08-29 2007-08-29
NZ61659208 2008-08-27

Publications (1)

Publication Number Publication Date
NZ706735A true NZ706735A (en) 2017-02-24

Family

ID=58055382

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ706735A NZ706735A (en) 2007-08-29 2008-08-27 Humanized anti-cxcr5 antibodies, derivatives thereof and their uses

Country Status (1)

Country Link
NZ (1) NZ706735A (en)

Similar Documents

Publication Publication Date Title
PH12015500248A1 (en) Humanized anti-cxcr5 antibodies, derivatives thereof and their uses
RS54795B1 (en) Anti-her3 antibodies and uses thereof
NZ599516A (en) Antibodies binding preferentially human csf1r extracellular domain 4 and their use
NZ599628A (en) Axl antibodies
NZ700891A (en) 4-1bb binding molecules
MX2010005888A (en) Bivalent, bispecific antibodies.
UA100874C2 (en) Bivalent bispecific antibodies
MX2010006396A (en) Bivalent, bispecific antibodies.
MX2010005682A (en) Bivalent, bispecific antibodies.
GEP20156390B (en) Antibody targeting through a modular recognition domain
EP4324480A3 (en) Anti-transferrin receptor antibodies and methods of use
UA111818C2 (en) ANTIBODY AGAINST CSF-1R
NZ602115A (en) Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
NZ586754A (en) Composition comprising antibody that binds to domain ii of her2 and acidic variants thereof
MX2009008104A (en) Hepcidin, hepcidin antagonists and methods of use.
MX2011011825A (en) Humanized axl antibodies.
NZ607588A (en) Antibodies against human TWEAK and uses thereof
NZ600470A (en) Anti-c4.4a antibodies and uses thereof
WO2012156532A8 (en) Anti-human-her3 antibodies and uses thereof
MX340555B (en) Antibodies against il-18r1 and uses thereof.
NZ616382A (en) Antibodies specific to cadherin-17
NZ629553A (en) Anti-big-endothelin-1 (big-et-1) antibodies and uses thereof
PL1987357T3 (en) Polypeptides recognized by anti-trichinella antibodies, and uses thereof
MX2012011829A (en) Anti-polyubiquitin antibodies and methods of use.
AU2008357729A8 (en) Antibodies against extracellular domain 2 and 3 of HER2

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 6 YEARS UNTIL 27 AUG 2018 BY WATERMARK INTELLECTUAL PROPERTY PTY LTD.

Effective date: 20170525

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 27 AUG 2019 BY CPA GLOBAL

Effective date: 20180712

LAPS Patent lapsed